Roche Holdings
Pharmaceutical & Health Products · Lobbying Client
B
Influence Score
63/100
High Influence
$10.8M
Total Lobby Spend
4
Policy Issues
4
Lobbyists
2
Revolving Door
Roche Holdings reported $10.8 million in federal lobbying expenditures as disclosed in Senate LDA filings. The organization's lobbying activity spans 4 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995.
Annual Lobbying Spend
Policy Issues
Government Entities Contacted
Dept of Energy
Dept of Defense
Food & Drug Administration
Dept of Transportation
Federal Trade Commission
Dept of Interior
Recent Filings
| Period | Registrant | Issues | Lobbyists | Amount |
|---|---|---|---|---|
| 2020 Jan-Mar | Cassidy & Associates LLP | GOVMEDPHA | 3 | $341K |
| 2020 Apr-Jun | Squire Patton Boggs LLP | PHAGOVMED | 3 | $517K |
| 2020 Jul-Sep | Akin Gump LLP | HCRGOVPHA+1 | 3 | $413K |
| 2020 Oct-Dec | Covington & Burling LLP | PHAGOVMED | 2 | $362K |
| 2021 Jan-Mar | K&L Gates LLP | HCRGOVMED+1 | 3 | $793K |
| 2021 Apr-Jun | Brownstein Hyatt LLP | HCR | 3 | $686K |
| 2021 Jul-Sep | BGR Group LLP | GOV | 4 | $605K |
| 2021 Oct-Dec | Brownstein Hyatt LLP | HCRMEDPHA+1 | 2 | $769K |